Noncoding RNAs in cancer therapy resistance and targeted drug development

WT Wang, C Han, YM Sun, TQ Chen… - Journal of hematology & …, 2019 - Springer
Noncoding RNAs (ncRNAs) represent a large segment of the human transcriptome and
have been shown to play important roles in cellular physiology and disease pathogenesis …

MicroRNAome genome: a treasure for cancer diagnosis and therapy

I Berindan‐Neagoe, PC Monroig… - CA: a cancer journal …, 2014 - Wiley Online Library
The interplay between abnormalities in genes coding for proteins and noncoding
microRNAs (miRNAs) has been among the most exciting yet unexpected discoveries in …

Clinical significance of microRNAs in chronic and acute human leukemia

CH Yeh, R Moles, C Nicot - Molecular cancer, 2016 - Springer
Small non-coding microRNAs (miRNAs) are epigenetic regulators that target specific cellular
mRNA to modulate gene expression patterns and cellular signaling pathways. miRNAs are …

Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein

J Ishizawa, K Kojima, N Hail Jr, Y Tabe… - Pharmacology & …, 2015 - Elsevier
Nucleocytoplasmic trafficking of proteins/RNAs is essential to normal cellular function.
Indeed, accumulating evidence suggests that cancer cells escape anti-neoplastic …

miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia

TT Vu, F Stölzel, KW Wang, C Röllig, ML Tursky… - Leukemia, 2021 - nature.com
Abstract Pharmacological inhibition of MDM2/4, which activates the critical tumor suppressor
p53, has been gaining increasing interest as a strategy for the treatment of acute myeloid …

Therapeutic resistance in acute myeloid leukemia: the role of non-coding RNAs

A Zebisch, S Hatzl, M Pichler, A Wölfler… - International journal of …, 2016 - mdpi.com
Acute myeloid leukemia (AML) is caused by malignant transformation of hematopoietic stem
or progenitor cells and displays the most frequent acute leukemia in adults. Although some …

[HTML][HTML] Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia

X Huang, S Schwind, R Santhanam, AK Eisfeld… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Deregulation of microRNAs' expression frequently occurs in acute myeloid leukemia (AML).
Lower miR-181a expression is associated with worse outcomes, but the exact mechanisms …

Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis

JU Igietseme, Y Omosun, O Stuchlik, MS Reed… - PloS one, 2015 - journals.plos.org
Chlamydia trachomatis genital infection in women causes serious adverse reproductive
complications, and is a strong co-factor for human papilloma virus (HPV)-associated cervical …

MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia

L Bi, L Sun, Z Jin, S Zhang, Z Shen - Oncology letters, 2018 - spandidos-publications.com
MicroRNAs (miRs) have been demonstrated to perform important roles in normal
hematopoiesis and leukemogenesis. Accumulating evidence suggests that miR‑10a and …

Architecture of the human Ape1 interactome defines novel cancers signatures

D Ayyildiz, G Antoniali, C D'Ambrosio… - Scientific Reports, 2020 - nature.com
APE1 is essential in cancer cells due to its central role in the Base Excision Repair pathway
of DNA lesions and in the transcriptional regulation of genes involved in tumor progression …